Table 2.
The activity of (XOD) in the serum of experimental guinea pigs in different study groups
| XOD | Serum | |||||||
|---|---|---|---|---|---|---|---|---|
| C | E | A | E+A | T | E+T | A+T | E+A+T | |
| Mean | 1.123 | 2.263 | 0.810 | 1.438 | 0.512 | 0.834 | 0.240 | 0.338 |
| SD | 0.185 | 0.464 | 0.267 | 0.061 | 0.205 | 0.338 | 0.176 | 0.189 |
| Min | 0.83 | 1.76 | 0.52 | 1.36 | 0.32 | 0.32 | 0.10 | 0.18 |
| Max | 1.36 | 2.83 | 1.12 | 1.53 | 0.78 | 1.21 | 0.53 | 0.68 |
| SE | 0.08 | 0.21 | 0.13 | 0.03 | 0.10 | 0.17 | 0.09 | 0.08 |
| CV% | 16.45 | 20.51 | 32.92 | 4.25 | 40.08 | 40.56 | 73.54 | 55.87 |
| Test | T =5.59; | T=5.71; | T=9.41; | |||||
| p<0.001* | T=2.3;p<0.05* | T=4.32;p<0.01** | T=5.2;p<0.001* | p<0.001** | T=8.05;p<0.001* | p<0.001** | ||
C = control; E = endurance exercise; A = L-ascorbic acid; T = alpha-tocopherol;
*
compared with the control group;
**
compared with the endurance exercise group Content of XOD is expressed in nmol/mg proteinmin-1